CHENGDU, CHINA / ACCESSWIRE / September 29, 2020 / The 2020 Golden Panda Global Blockchain Innovation & Entrepreneurship Competition has been officially launched recently. It' s one of the most influential international competitions of "SHUANG CHUANG" (Innovation & Entrepreneurship) in China, sponsored by Chengdu Municipal People's Government and undertaken by Management Committee of Chengdu High-tech Zone. Focusing on the innovation and application of blockchain technology, the Competition will set up several sub-competition areas in Netherlands in Europe, Singapore in Asia-Pacific, and Hangzhou, Shenzhen and Chengdu in China. Through three stages of project collection, preliminary competition and review, the best projects selected from these areas will participate in the national finals held in Chengdu High-tech Zone at the end of October this year.

As one of the main activities of the 2020 Chengdu Global Innovation & Entrepreneurship Fair and the First International Blockchain Expo, the Competition is aimed at building a well-known brand of "SHUANG CHUANG Competition" in the world, and focuses on the recruitment of "high-quality talents, highly sophisticated technologies and high-quality projects". By providing platforms and open scenarios, the event will gather the world's top scientific and technological innovation talents, high-quality projects and social capital to promote the application innovation of blockchain and the landing of business scenes. The purpose of this competition is to recruit a wide range of technology-based enterprises or teams engaged in blockchain technology R&D and network security which are forward-looking and innovative and have independent intellectual properties. Combined with the open scenarios of community governance, smart city, finance and medical care, the Competition will explore the integration of blockchain with new technologies such as 5G, artificial intelligence, big data, Internet of Things, finance and intellectual property, and select excellent solutions for blockchain application.

This year's competition is divided into two tracks: the Basic Technology Innovation Competition and the Scene Innovation Application Competition. The track of Basic Technology Innovation Competition is an open competition. With its focus on blockchain technology in distributed computing, peer-to-peer transmission, data encryption, consensus algorithm, smart contract, etc., this track is aimed at collecting technical innovation solutions which are not limited to specific application scenarios, and highlight core technologies, application efficiency, industry value, etc. The track of Scenario Innovation Application Competition is a proposition competition. It will collect solutions for the application of blockchain technology in designated scenarios which try to find out the industry pain points and improve social efficiency through the application model of blockchain products. Each track of the Competition will set up one first prize, two second prizes and three third prizes with a reward of RMB100,000, RMB80,000 or RMB50,000 respectively for each winner.

It is worth mentioning that the participating enterprises winning the first prize in the Scene Innovation Application Competition and landed in Chengdu High-tech Zone will have the opportunity to implement the application scene pilot project. They will not only get rich competition prizes, but also get real business orders from the government for related projects, which will be a rare case practice and development opportunity for all blockchain innovation & entrepreneurship teams.

It is reported that the first blockchain intellectual property base of the country will land in JINGRONGHUI, Chengdu High-tech Zone, and create a new base of blockchain intellectual property with the greatest demonstration, promotion and influence in Southwest Chin. In order to attract outstanding projects and talents, in addition to competition prizes and business orders, the Competition will continue to introduce innovative talents to settle in Chengdu High-tech Zone by the mode of replacing investment with competitions. Chengdu High-tech Zone will provide start-up funds and rent subsidies for the outstanding projects which have won the competition and landed in the Zone. Besides, these projects will also enjoy many preferential policies such as equity financing subsidies, talent settlement, children's enrollment, etc., and have opportunities to link to international venture capital resources to help Chengdu build an international business environment benchmark city.

Now, the registration channel has been opened for participants to sign up through the following link: http://gp.cdibi.org.cn/.The deadline for registration is October 14th.

Contact:

Chongqing Nandu Media Co.,Ltd.
Fiona Lee
fiona@cqndcm.com
+8618716408771
http://gp.cdibi.org.cn/

SOURCE: The 2020 Golden Panda Global Blockchain Innovation & Entrepreneurship Competition

ReleaseID: 608430

DOVER, DE / ACCESSWIRE / September 29, 2020 / On September 24, 2020, Hero Technologies Inc. (OTC PINK:HENC), formerly known as Holloman Energy Corporation, announces the resignation of Patricia Smart, and the appointment of Gina Serkasevich as Sole Director and Chief Executive Officer.

"We are pleased that Gina Serkasevich has accepted this role," stated Destiny Aigbe, Majority Shareholder, "We believe Ms. Serkasevich will be instrumental in moving Hero Technologies into its forthcoming stages of growth. We would also like to thank Patricia Smart for her contributions and wish her the best on her future endeavors."

Gina Serkasevich, CMA, CPA is the CFO for Hero Technologies (formerly Holloman Energy) and has been with the Company since June 2013. She has more than 30 years of domestic and international corporate accounting and finance experience. Ms. Serkasevich held the position as Director of Finance at Holloman Corporation from June 2012 to July 2020, which is one of the largest employee owned engineering and construction companies in the United States. Prior to 2012, Ms. Serkasevich had served in the Oil and Gas Tanker Transportation industry in a variety of positions including Regional Financial Manager, Financial Consultant, Financial Controller/CFO and held the Company Secretary position on two boards of directors.

ON BEHALF OF THE BOARD OF DIRECTORS

Hero Technologies Inc.

Contact:

Hero Technologies Inc.
Gina Serkasevich
(713) 992-7858

Forward-Looking Statements:

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. These statements are not guaranties of future performance, and actual results may differ materially from those forecasted.

The company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words believe, anticipate, intends, estimate, forecast, project, plan, potential, may, should, expect, pending, and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs, or projections.

SOURCE: Hero Technologies Inc.

ReleaseID: 608382

BELLEVUE, WA / ACCESSWIRE / September 29, 2020 / Trilogy International Partners Inc. (TSX:TRL), an international wireless and fixed broadband telecommunications operator, announced today that it will report results for the third quarter ended September 30, 2020, after the markets close on Tuesday, November 10, 2020. The company will hold a conference call to discuss the results the next day, November 11, 2020, at 10:30 a.m. (PT).

Dial-in and online information for the conference call follows below.

No access code is required; please ask the operator to be joined into the Trilogy International Partners (TRL) call.

Call Date: Wednesday, November 11, 2020
Call Time: 10:30 a.m. (PT)
North America Toll Free: 1-844-369-8770
International: +1-862-298-0840
Online info (audio only):

https://www.webcaster4.com/Webcast/Page/2180/37744

Live simulcast (listen only) available during the call. Participants should register on the website approximately 10 minutes prior to the start of the webcast.

A replay of the conference call will be available at approximately 12:30 p.m. (PT) the day of the live call. Replay dial-in access is as follows:

North America Toll Free: 1-877-481-4010
International: +1-919-882-2331
Replay Access Code: 37744

About Trilogy International Partners Inc.

Trilogy International Partners Inc. (TSX:TRL) is the parent company of Trilogy International Partners LLC, a wireless and fixed broadband telecommunications operator formed by wireless industry veterans John Stanton, Theresa Gillespie and Brad Horwitz. Trilogy's founders have an exceptional track record of successfully buying, building, launching and operating communication businesses in 15 international markets and the United States.

Trilogy currently provides wireless communications services through its operating subsidiaries in New Zealand and Bolivia. Its head office is located at 155 108th Avenue NE, Suite 400, Bellevue, Washington, 98004 USA.

For more information, visit www.trilogy-international.com.

CONTACT:

Trilogy International Partners Inc.
Ann Saxton
Vice President, Investor Relations & Corporate Development
+1 (425) 458-5900

SOURCE: Trilogy International Partners Inc.

ReleaseID: 608053

TORONTO, ONTARIO / ACCESSWIRE / September 29, 2020 / Electrovaya Inc. ("Electrovaya") (TSX:EFL)(OTCQB:EFLVF) completed the repayment of its $15 million unsecured 9% convertible debentures by the payment of the remaining $2 million due September 29, 2020 to the debenture holder, an institutional investor. The terms of the debentures were previously amended as disclosed in a news release dated April 8, 2020 and have now been fully repaid.

To repay the remaining amount outstanding under the debentures, Electrovaya amended an existing promissory note with a Canadian financial institution to increase the amount outstanding thereunder from $2.83 million to $6 million, which allowed the repayment of the remaining $2 million of the debentures and made an additional $1.17 million available for Electrovaya's use for general corporate purposes.

Electrovaya had also previously entered into two purchase order facilities of $5.5 million and $4.5 million for a total of $10 million from the same Canadian financial institution. Both these facilities have recently been repaid from Electrovaya's operating cash flows. These loans were specifically for the fulfilment of battery deliveries to Walmart Canada and to a Raymond Corporation client in the USA, respectively.

Electrovaya continues to operate a $7 million revolving working capital credit facility for its growing business in lithium ion batteries. All currencies above are in Canadian dollars.

For more information:
Investor Contact:
Jason Roy
Electrovaya Inc.
Telephone: 905-855-4618
Email: jroy@electrovaya.com

Media Contact:
Peter Koven
Bay Street Communications
Telephone: 647-496-7857
Email: peterkoven@baystreetcommunications

About Electrovaya Inc.
Electrovaya Inc. (TSX:EFL)(OTCQB:EFLVF) designs, develops and manufactures proprietary Lithium Ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. Electrovaya is a technology focused company with extensive IP. Headquartered in Ontario, Canada, Electrovaya has production facilities in Canada with customers around the globe.

To learn more about how Electrovaya is powering mobility and energy storage, please explore www.electrovaya.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements, including statements that relate to, among other things: the anticipated satisfaction of outstanding debt and the timing thereof; the terms of the loan and promissory note facility; and the Company's objectives, goals, strategies, intentions, beliefs, expectations and estimates. Forward-looking statements can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and investors should place undue reliance on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, among other things, that the Company will be able to satisfy its outstanding debt within contractually agreed upon timeframes, that customers will continue to make and increase orders for the Company's products, that the Company's alternate supply chain will be adequate to replace material supply and manufacturing and that the Company will be able to operate effectively and have adequate liquidity and capital resources to continue operations and satisfy purchase orders during the ongoing global pandemic crisis related to COVID-19, which has negatively impacted, among other things, global supply chains, raw material availability, employee availability, and customer capacity. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Annual Information Form for the year ended September 30, 2019 and in the Company's most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Electrovaya, Inc.

ReleaseID: 608379

PHOENIX, AZ / ACCESSWIRE / September 29, 2020 / Crexendo, Inc. (NASDAQ:CXDO), an award-winning premier provider of cloud communications, UCaaS (Unified Communications as a Service), call center, collaboration services, and other cloud business services that are designed to provide enterprise-class cloud services to any size business at affordable monthly rates, today announced that Crexendo is scheduled to present at the October 2020 Lytham Partners Virtual Investor Growth Conference. The Company will present on Thursday, October 8, 2020 at 3:00 PM Eastern., the conference this year will be done as a virtual conference.

Doug Gaylor, President and Chief Operating Officer and Ron Vincent, Chief Financial Officer of Crexendo, will be conducting one-on-one meetings with investors on Tuesday and Wednesday Oct 6 and 7. To arrange a meeting, please contact Lytham Partners at 1×1@lythampartners.com or visit www.lythampartners.com/virtual.

About Crexendo

Crexendo, Inc. is an award-winning premier provider of UCaaS (Unified Communications as a Service), call center, collaboration services, and other cloud business services that are designed to provide enterprise-class cloud services to any size business at affordable monthly rates.

Safe Harbor Statement

This press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. The words "believe," "expect," "anticipate," "estimate," "will" and other similar statements of expectation identify forward-looking statements.

For a more detailed discussion of risk factors that may affect Crexendo's operations and results, please refer to the company's Form 10-K for the year ended December 31, 2019, and quarterly Form 10-Qs as filed with the SEC. These forward-looking statements speak only as of the date on which such statements are made, and the company undertakes no obligation to update such forward-looking statements, except as required by law.

CONTACT:

Crexendo, Inc.
Doug Gaylor
President and Chief Operating Officer
602-732-7990
dgaylor@crexendo.com

SOURCE: Crexendo, Inc.

ReleaseID: 608289

Study conducted in Peru and Panama
Trial involves 690 participants, including older adults
Evaluation of safety, reactogenicity and immunogenicity

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 29, 2020 / CureVac N.V. (NASDAQ:CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced today that the first participant has been dosed in a Phase 2a clinical trial of its COVID-19 vaccine candidate, CVnCoV. The dose-confirmation study, entitled CV-NCOV-002, is being conducted in Peru and Panama and will enroll a total of 690 healthy participants in two distinct groups: older adults ages 61 and above, and younger participants 18 to 60 years old.

The participants will receive two vaccinations at intervals of 28 days. Different dose levels will be investigated, starting at 6 µg, with the aims to confirm safety and evaluate reactogenicity of the vaccine in older adults. In addition, in a geographical environment with a high incidence of COVID-19 infection, the humoral immune response after administration of CVnCoV will be assessed and the safety database will be expanded to prepare for the start of a phase 2b/3 study. First comprehensive data of Phase 2a in older adults are expected later in the fourth quarter 2020.

The study design was coordinated with and approved by the health authorities and ethics committees of Peru and Panama and is based on preliminary safety and immunogenicity data from CureVac's ongoing Phase 1 CV-NCOV-001 study in healthy adult volunteers in Germany and Belgium. Pending further data from the ongoing Phase 1 and the Phase 2a study, CureVac plans to initiate the global Phase 2b/3 clinical trial enrolling approximately 30,000 participants in the fourth quarter of 2020.

"The start of the clinical Phase 2a trial in Peru and Panama represents an important step forward in our COVID-19 clinical study program," Dr. Mariola Fotin-Mleczek, Chief Technology Officer of CureVac, said. "This trial is designed to further confirm the selection of the dose of our vaccine candidate and to confirm that we can provide a safe and tolerable vaccine, also to older adults, who are at a higher risk of experiencing serious impacts from COVID-19."

About CVnCoV

CureVac first began development of its mRNA-based COVID-19 vaccine candidate in January 2020. After extensive preclinical development, the company began its Phase 1 clinical study of CVnCoV in June 2020 at clinical study centers in Germany and Belgium. The company has substantial production capacities for mRNA vaccines at its headquarters in Tübingen and is currently expanding those manufacturing capacities to allow for broad-scale manufacturing of CVnCoV and other mRNA-based vaccines.

About CureVac

CureVac is a global clinical-stage biopharmaceutical company in the field of messenger RNA (mRNA) technology with expertise in developing and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of prophylactic vaccines, cancer therapies, antibody therapies and the treatment of rare diseases. CureVac is headquartered in Tübingen, Germany with sites in Frankfurt and Boston, USA.

CureVac Media Contact
Thorsten Schüller, Vice President Communications
CureVac, Tübingen, Germany
T: +49 7071 9883-1577
thorsten.schueller@curevac.com

CureVac Investor Relations Contact
Dr. Sarah Fakih, Vice President Investor Relations
CureVac, Tübingen, Germany
T: +49 7071 9883-1298
M: +49 160 90 496949
sarah.fakih@curevac.com

Contact for Latin American Journalists
Gloria Niño de Rivera
Face-to-Face Proyección y Cuidado de Asuntos Corporativos, S.C.
01330 Ciudad de México
México
Dir: +52 55 5292 3568 | Mobile: +521 55 5076 1524
glorianr@facetofacelatam.onmicrosoft.com

Forward-Looking Statements
This press release contains statements that constitute "forward looking statements" as that term is defined in the United States Private Securities Litigation Reform Act of 1995, including statements that express the opinions, expectations, beliefs, plans, objectives, assumptions or projections of CureVac (the "company") regarding future events or future results, in contrast with statements that reflect historical facts. Examples include discussion of the company's strategies, financing plans, growth opportunities and market growth. In some cases, you can identify such forward-looking statements by terminology such as "anticipate," "intend," "believe," "estimate," "plan," "seek," "project," or "expect," "may," "will," "would," "could," "potential," "intend," or "should," the negative of these terms or similar expressions. Forward-looking statements are based on management's current beliefs and assumptions and on information currently available to the company. However, these forward-looking statements are not a guarantee of the company's performance, and you should not place undue reliance on such statements. Forward-looking statements are subject to many risks, uncertainties and other variable circumstances, including negative worldwide economic conditions and ongoing instability and volatility in the worldwide financial markets, ability to obtain funding, ability to conduct current and future preclinical studies and clinical trials, the timing, expense and uncertainty of regulatory approval, reliance on third parties and collaboration partners, ability to commercialize products, ability to manufacture any products, possible changes in current and proposed legislation, regulations and governmental policies, pressures from increasing competition and consolidation in the company's industry, the effects of the COVID-19 pandemic on the company's business and results of operations, ability to manage growth, reliance on key personnel, reliance on intellectual property protection, ability to provide for patient safety, and fluctuations of operating results due to the effect of exchange rates or other factors. Such risks and uncertainties may cause the statements to be inaccurate and readers are cautioned not to place undue reliance on such statements. Many of these risks are outside of the company's control and could cause its actual results to differ materially from those it thought would occur. The forward-looking statements included in this press release are made only as of the date hereof. The company does not undertake, and specifically declines, any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments, except as required by law.

For further information, please reference the company's reports and documents filed with the U.S. Securities and Exchange Commission (SEC). You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.

SOURCE: CureVac N.V.

ReleaseID: 608372

VANCOUVER, BC / ACCESSWIRE / September 29, 2020 / CounterPath Corporation ("CounterPath" or the "Company") (NASDAQ:CPAH)(TSX:PATH), a global provider of award-winning Unified Communications and Collaboration (UCC) solutions for enterprises and service providers, announced that, at its annual meeting held September 24, 2020 (the "Meeting"), all of the nominees for election as directors of CounterPath referred to in its definitive proxy statement dated August 20, 2020 for the Meeting were elected.

A total of 4,948,893 common shares representing 77.19% of the outstanding common shares were present in person or by proxy at the Meeting. The result of the votes held, either in person or by proxy, were as follows:

Resolution

Vote Type

Total Votes

% Voted

Steven Bruk

For

3,647,725

97.08%

Against

97,946

2.61%

Withheld

11,728

0.31%

Chris Cooper

For

3,414,820

90.88%

Against

322,185

8.57%

Withheld

20,394

0.54%

Bruce Joyce

For

3,639,484

96.86%

Against

97,521

2.60%

Withheld

20,394

0.54%

Owen Matthews

For

3,636,973

96.79%

Against

108,472

2.89%

Withheld

11,954

0.32%

Terence Matthews

For

3,636,973

96.79%

Against

108,472

2.89%

Withheld

11,954

0.32%

Larry Timlick

For

3,645,529

97.02%

Against

99,976

2.66%

Withheld

11,894

0.32%

The results of other matters considered at the Meeting are reported in the Report of Voting Results as filed on SEDAR (www.sedar.com) filed on September 29, 2020 and the Form 8-K as filed on EDGAR (http://www.sec.gov/edgar.shtml), filed on September 29, 2020.

About CounterPath

CounterPath Corporation (NASDAQ: CPAH) is revolutionizing how people communicate in today's modern mobile workforce. Its award-winning Bria solutions for desktop and mobile devices enable organizations to leverage their existing PBX and hosted voice call servers to extend seamless and secure unified communications and collaboration services to users regardless of their location and network. CounterPath technology meets the unique requirements of several industries, including the contact center, retail, warehouse, hospitality, and healthcare verticals. Its solutions are deployed worldwide by 8×8, Airbnb, AmeriSave, Aspect, BT, Citibank, Comcast, Fusion, Fuze, Honeywell, Liberty Global, Windstream and others. Learn more at counterpath.com and follow us on Twitter @counterpath.

Contacts:

David Karp
Chief Executive Officer
dkarp@counterpath.com

SOURCE: CounterPath Corporation

ReleaseID: 608137